Cargando…

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts

OBJECTIVE: This study evaluates exercise participation in patients with rheumatoid arthritis (RA) and the percentage of patients that meet the recommended level of physical activity (at least 150 minutes per week moderate-intensity physical activity) in two cross-sectional questionnaires in 2013 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weijers, Julia M., Rongen-van Dartel, Sanne A.A., van Riel, Piet L.C.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045938/ https://www.ncbi.nlm.nih.gov/pubmed/32185327 http://dx.doi.org/10.31138/mjr.29.4.199

Ejemplares similares

Patients’ experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands
por: Renskers, Lisanne, et al.
Publicado: (2020)

Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
por: Müskens, Wieland D., et al.
Publicado: (2019)

Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization
por: Müskens, Wieland D, et al.
Publicado: (2021)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry
por: Manders, Sofie H M, et al.
Publicado: (2015)

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
por: Hendrikx, Jos, et al.
Publicado: (2016)

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology
por: Müskens, Wieland D, et al.
Publicado: (2020)

A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA
por: Semb, Anne Grete, et al.
Publicado: (2022)

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis
por: Siemons, Liseth, et al.
Publicado: (2014)

Calibration of the PROMIS Physical Function Item Bank in Dutch Patients with Rheumatoid Arthritis
por: Oude Voshaar, Martijn A. H., et al.
Publicado: (2014)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
por: Flendrie, Marcel, et al.
Publicado: (2005)

IL2RA is associated with persistence of rheumatoid arthritis
por: van Steenbergen, H.W., et al.
Publicado: (2015)

Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
por: Vermeer, Marloes, et al.
Publicado: (2012)

Immune responses to stress after stress management training in patients with rheumatoid arthritis
por: de Brouwer, Sabine JM, et al.
Publicado: (2013)

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
por: van den Bemt, Bart JF, et al.
Publicado: (2011)

The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis
por: De Winter, Liesbeth M., et al.
Publicado: (2016)

Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis
por: ten Klooster, Peter M, et al.
Publicado: (2013)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
por: Vermeer, Marloes, et al.
Publicado: (2013)

Has the rheumatoid arthritis (RA) core outcome set influenced the selection of study outcome measures?
por: Kirkham, Jamie, et al.
Publicado: (2013)

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
por: Arts, Elke, et al.
Publicado: (2012)

Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis
por: ten Klooster, Peter M, et al.
Publicado: (2013)

Lysozyme and its biological value in rheumatoid arthritis (RA)
por: Smirnow, J, et al.
Publicado: (2001)

Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates
por: Molina, Emily, et al.
Publicado: (2015)

Evaluating quality of care in rheumatoid arthritis: the patient perspective
por: Mahmood, Sehrash, et al.
Publicado: (2017)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis
por: Toonen, Erik JM, et al.
Publicado: (2012)

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme
por: Yamanaka, Hisashi, et al.
Publicado: (2017)

Prospective Studies on the Risk of Rheumatoid Arthritis: The European Risk RA Registry
por: Studenic, Paul, et al.
Publicado: (2022)

Intestinal anaerobic bacteria in early rheumatoid arthritis (RA)
por: Toivanen, P, et al.
Publicado: (2002)

Work participation is reduced during the development of RA, months before clinical arthritis manifests
por: Rogier, Cleo, et al.
Publicado: (2021)

Macrophage dysfunction in Psoriatic Arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare
por: Hendrikx, Jos, et al.
Publicado: (2015)

Effects of an Exercise Program and Cold-Water Immersion Recovery in Patients with Rheumatoid Arthritis (RA): Feasibility Study
por: Peres, Daniele, et al.
Publicado: (2023)

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
por: Crowson, Cynthia S., et al.
Publicado: (2017)

Premature Ejaculatory Dysfunction in Rheumatoid Arthritis (PED-RA Study)
por: Wagan, Abrar Ahmed, et al.
Publicado: (2022)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

Genome-wide gene expression in experimental arthritis: defining new targets of chronic/destructive rheumatoid arthritis (RA)
por: Takahashi, N, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_c5c75rlvaj76ht4505pqn8o6m6